Page 27 - Home Care Catalogue Edition 4A
P. 27

Why use a breathing  lter
Breathing  lters are designed to prevent microbial cross contamination which can occur via patients, ventilator breathing systems and respiratory equipment. Their use has been widely recognised as an effective method of reducing cross contamination and has been recommended by a number of medical associations1.
The threat to patients is varied
Patients requiring respiratory support at home may be exposed to the risk of cross contamination from the equipment, breathing systems or the environment. Documented areas of concern regarding infection from breathing systems include Hepatitis C, Mycobacterium tuberculosis, blood in sputum and the SARS virus.
Long term ventilated patients may be at risk from pseudomonal growth in the breathing system and in water bath humidi ers. The strategic use of an effective breathing  lter protects both the patient and equipment bi-directionally, helping to prevent infection.
Effective use of  lters in the homecare environment can also help protect the respiratory equipment which the patient relies upon, as well as helping to optimise its function and helping to prolong its life.
Effective validated performance
The Intersurgical range of breathing systems has been designed for the protection of the patient, breathing system and equipment. They have been independently tested and proven to be highly ef cient in preventing the passage of bacteria and viruses, which would result in contamination.
The wide and varied product range offers:
• Validated bacterial and viral  ltration ef ciency2
• Proven Filtration against TB and Hepatitis C
• Choice of patient connections – optimising patient comfort • Compatible with respiratory equipment
• Lightweight – improving patient comfort
• Low resistance to  ow
Potential infectious viruses [Particle sizes μ microns] Coliphage T1 [0.017μ]
MS-2 coliphage [0.02μ] Hepatitis C [0.03μ] Adenovirus [0.07μ]
Mycobacterium tuberculosis
[0.3μ x 1.0μ smallest size] Serratia marcescens [0.45μ]
Pseudomonas aeruginosa [0.5μ] Brevundimonas diminuta [0.3μ]
HIV [0.11μ]
Cytomegalovirus (CMV) [0.1μ] Orthomyxovirus [0.1μ]
Staphylococcus aureus [1.0μ]
Bacillus subtilis [1.0μ x 0.7μ]
Breathing Filters, HMEs and HMEFs • Breathing Filters
1. Association of Anaesthetists of Great Britain and Ireland 1996. Danish Society of Anaesthetists 1998. French Society of Anaesthetists 1998.
2. All  lters are independently validated for  ltration ef ciency at the Health Protection Agency, Porton Down, Salisbury, Wiltshire, UK and Nelson laboratories Inc, USA.
Contact us •

   25   26   27   28   29